ropidoxuridine
ropidoxuridine: developed by 1 company · 1 clinical trial tracked. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | Phase 2 |
Clinical Trials (1)
Phase 2 Study of Ropidoxuridine as a Radiation Sensitizing Agent During Radiotherapy in Patients With Newly Diagnosed IDH-Wildtype Glioblastoma With Unmethylated MGMT Promoter
Frequently asked questions
Who is developing ropidoxuridine?
ropidoxuridine is being developed by Shuttle Pharmaceuticals Holdings, Inc..
How many clinical trials involve ropidoxuridine?
BioSniper tracks 1 clinical trial involving ropidoxuridine.
Get deeper analysis on ropidoxuridine
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis